Ga 68 PSMA-11 (Illuccix) Report issue

Small molecule Imaging Approved FDA
AACT

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: O=C([O-])CN(CCN(CC(=O)[O-])Cc1cc(CCC(=O)NCCCCCC(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)ccc1[O-])Cc1cc(CCC(=O)O)ccc1[O-].[68Ga+3].[OH3+]
  • InChIKey: ZSLQZWHCPBAGKD-RDIOTIBJSA-K
  • Mol. Mass: 1029.92
  • ALogP: 1.55
  • ChEMBL Molecule:
    gallium ga 68 gozetotide  
More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

68ga hbed-cc psma | 68ga-hbed-cc-psma | 68ga-psma | 68ga psma-hbed-cc | 68ga-psma-hbed-cc | ga 68-labeled psma ligand glu-urea-lys(ahx) | ga 68-labeled psma ligand glu-urea-lys(ahx)-hbed-cc | ga 68-psma | ga68 psma-11 | ga-hbed-ipsma | gallium-68 psma-11 | gallium-68 psma-hbed-cc | psma-11

Organizations (68)

Research & Development (68)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (4)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (14)

Approved Indications (1)


 

Prostatic Neoplasms

Experimental Indications - Clinical Trial Phases 1-4 (14)


 

Breast Neoplasms (Phase 1)

Carcinoma, Adenoid Cystic (Early Phase 1)

Carcinoma, Hepatocellular (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Ovarian Neoplasms (Early Phase 1)

Positron-Emission Tomography (Early Phase 1)

Positron Emission Tomography Computed Tomography (Early Phase 1)

Prostatic Neoplasms (Phase 3)

Prostatic Neoplasms, Castration-Resistant (Phase 3)

Recurrence (Phase 3)

Sarcoma (Phase 1)

Thyroid Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 99
  • # of Trial Organizations: 68

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue